Drug Approvals

Pfizer Inc.  (PFE)  shares leapt greater Tuesday after the drugmaker posted stronger-than-expected second quarter earnings, whereas boosting its vaccine gross sales forecast, amid the continued demand for its Covid vaccine and antiviral…

Merck & Co.  (MRK)  posted better-than-expected third quarter earnings Thursday, whereas lifting its full-year revenue steering for a second time, thanks partly to spectacular gross sales of its blockbuster most cancers therapy…